MARKET

SERA

SERA

Sera Prognostics, Inc.
NASDAQ
1.690
-0.040
-2.31%
Closed 19:58 05/12 EDT
OPEN
1.740
PREV CLOSE
1.730
HIGH
1.820
LOW
1.650
VOLUME
77.32K
TURNOVER
0
52 WEEK HIGH
4.090
52 WEEK LOW
1.370
MARKET CAP
66.18M
P/E (TTM)
-2.4352
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SERA last week (0504-0508)?
Weekly Report · 2d ago
Sera Prognostics Balances Cash Strength With Slow Ramp
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Gilead Sciences (GILD) and Sera Prognostics (SERA)
TipRanks · 5d ago
Sera projects cash runway through 2029 while targeting nearly $10M annual operating expense reduction
Seeking Alpha · 6d ago
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Sera Prognostics (SERA)
TipRanks · 6d ago
Sera Prognostics reports Q1 EPS (17c), consensus (17c)
TipRanks · 6d ago
Press Release: SERA PROGNOSTICS REPORTS FIRST -2-
Dow Jones · 6d ago
Sera Prognostics Q1 revenue falls sharply, net loss widens
Reuters · 6d ago
More
About SERA
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.

Webull offers Sera Prognostics Inc stock information, including NASDAQ: SERA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SERA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SERA stock methods without spending real money on the virtual paper trading platform.